Delving into the Latest Updates on Henan Analysis and Test Center with Synapse

Overview

Tags

Immune System Diseases

Hemic and Lymphatic Diseases

Respiratory Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	1
Infectious Diseases	1
Immune System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

RdRp(RNA-directed RNA polymerase)	1

主要目的： 1、评价阿兹夫定片（FNC）联合逆转录酶抑制剂治疗未接受过抗HIV病毒治疗的感染者的安全性； 2、初步评价阿兹夫定片（FNC）联合逆转录酶抑制剂治疗未接受过抗HIV病毒治疗的感染者的有效性；次要目的：探索阿兹夫定片（FNC）临床使用有效剂量。

[Translation]

Main objectives: 1. To evaluate the safety of Azvudine Tablets (FNC) combined with reverse transcriptase inhibitors in the treatment of HIV-infected patients who have not received anti-HIV treatment; 2. To preliminarily evaluate the effectiveness of Azvudine Tablets (FNC) combined with reverse transcriptase inhibitors in the treatment of HIV-infected patients who have not received anti-HIV treatment; Secondary objectives: To explore the effective dose of Azvudine Tablets (FNC) for clinical use.

Start Date23 Oct 2017

Sponsor / Collaborator

Henan Analysis and Test Center

[+1]

CTR20171344 / Active, not recruitingPhase 1

阿兹夫定片在未接受过抗HIV病毒治疗的感染者中多次给药安全性的临床研究

[Translation] Clinical study on the safety of multiple doses of azithromycin tablets in HIV-infected patients who have not received antiviral treatment

主要目的：评价未接受过抗HIV病毒治疗的感染者多次口服阿兹夫定片后的安全性。次要目的：观察未接受过抗HIV病毒治疗的感染者多次口服阿兹夫定片后的初步疗效。

[Translation]

Primary objective: To evaluate the safety of multiple oral administration of Azvudine tablets in HIV-infected patients who have not received antiviral treatment. Secondary objective: To observe the preliminary efficacy of multiple oral administration of Azvudine tablets in HIV-infected patients who have not received antiviral treatment.

Start Date21 Aug 2017

Sponsor / Collaborator

Henan Analysis and Test Center

[+1]

100 Clinical Results associated with Henan Analysis and Test Center

Login to view more data

0 Patents (Medical) associated with Henan Analysis and Test Center

Login to view more data

6

Literatures (Medical) associated with Henan Analysis and Test Center

01 Mar 2000·Se pu = Chinese journal of chromatography

[Analysis of imidacloprid and damanlin by high performance liquid chromatography].

Article

Author: Liu, P ; Chen, R F ; He, J ; Chang, J B ; Wang, Q ; Lin, S F ; Guo, R Y

A new method for determination of imidacloprid and damanlin by using HPLC was established. It was carried out on a mu Bondapak C18 column (3.9 mm i.d. x 300 mm) with ACN-MeOH-H2O (60:10:30, V/V) as eluent and detected at 240 nm using photodiode array detector. The results of imidacloprid and damanlin were 3.71% and 15.65% respectively. The standard deviations for imidacloprid and damanlin were 0.88% and 0.76% respectively.

01 Jul 1999·Se pu = Chinese journal of chromatography

[Determination of sarafloxacin by high performance liquid chromatography (HPLC)].

Article

Author: Kuang, A ; Guo, R ; Chang, J ; He, J ; Lin, S ; Liu, P

A method for the separation and determination of Sarafloxacin by HPLC was developed. The sample was dissolved in a mixture of V(acetonitrile):V(water) = 1:1. Operating conditions were as follows: mu-Bondapak C18 column (3.9 mm x 300 mm), V(acetonitrile):V(methanol):V(2 mmol/L H3PO4, adjust pH 3.5 with triethylamine) = 30:5:65 as mobile phase with a flow rate of 1 mL/min, UV detection at 278 nm, and column temperature was 15 degrees C. Under the above conditions, Sarafloxacin and other impurities were separated from each other. The method was simple, rapid, sensitive and accurate.

Sepu

Analysis of imidacloprid and damanlin by high performance liquid chromatography

Author: Wang, Qiang ; Chang, Jun-biao ; Chen, Rong-feng ; Lin, Su-feng ; Guo, Rui-yun ; Liu, Peng ; He, Juan

A new method for determination of imidacloprid and damanlin by using HPLC was established.It was carried out on a μBondapak C₁₈ column (3.9 mm i.d. × 300 mm) with ACN-MeOH-H₂O (60:10:30, V/V ) as eluent and detected at 240 nm using photodiode array detector.The results of imidacloprid and damanlin were 3.71% and 15.65% resp.The standard deviations for imidacloprid and damanlin were 0.88% and 0.76% resp.

100 Deals associated with Henan Analysis and Test Center

Login to view more data

100 Translational Medicine associated with Henan Analysis and Test Center

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data